CRIXIVAN Side Effects

7015599-9 | Polyneuropathy
on Sep 23, 2010 Male patient from NETHERLANDS , 35 years of age, weighting 158.7 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: polyneuropathy. Crixivan dosage: .

6902158-9 | Blood Lactic Acid Increased, Diplopia, Dysphagia, Eyelid Ptosis, Lipodystrophy Acquired, Mitochondrial Toxicity, Progressive External Ophthalmoplegia
Patient was taking Crixivan (View Usage). Patient had the following side effects: blood lactic acid increased, diplopia, dysphagia, eyelid ptosis, lipodystrophy acquired, mitochondrial toxicity, progressive external ophthalmoplegia on Jul 23, 2010 from CANADA Additional patient health information: Male patient , 54 years of age, . Crixivan dosage: . During the same period patient was treated with FUZEON (View Fuzeon Review and Fuzeon Label ), KALETRA (View Kaletra Review and Kaletra Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), REYATAZ (View Reyataz Review and Reyataz Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ).

6900715-7 | Abdominal Pain, Fatigue, Hallucination, Insomnia, Rash
Adverse event was reported on Jul 23, 2010 by a Male patient taking Crixivan (View Usage) (Dosage: ) . Location: CANADA , 26 years of age, After Crixivan was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), fatigue, hallucination, insomnia, rash (What is rash?). During the same period patient was treated with ATRIPLA (View Atripla Review and Atripla Label ), PREZISTA (View Prezista Review and Prezista Label ), RESCRIPTOR (View Rescriptor Review and Rescriptor Label ), REYATAZ (View Reyataz Review and Reyataz Label ), TRUVADA (View Truvada Review and Truvada Label ), ZERIT (View Zerit Review and Zerit Label ), ZIAGEN (View Ziagen Review and Ziagen Label ).

6720502-2 | Abdominal Distension, Cardiac Murmur, Congenital Abdominal Hernia, Congenital Anomaly, Cryptorchism
on May 07, 2010 Male patient from UNITED KINGDOM , weighting 6.61 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, cardiac murmur, congenital abdominal hernia, congenital anomaly, cryptorchism. Crixivan dosage: . During the same period patient was treated with LAMIVUDINE AND ZIDOVUDINE (View Lamivudine And Zidovudine Review and Lamivudine And Zidovudine Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), TENOFOVIR DISOPROXIL FUMARATE AND EMTRICITABINE (View Tenofovir Disoproxil Fumarate And Emtricitabine Review and Tenofovir Disoproxil Fumarate And Emtricitabine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).


6619259-5 | Dizziness, Palpitations, Pulmonary Hypertension
on Feb 23, 2010 Male patient from JAPAN , 24 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). Patient had the following side effects: dizziness (What is dizziness?), palpitations, pulmonary hypertension (What is pulmonary hypertension?). Crixivan dosage: 800 Mg/daily, Po. During the same period patient was treated with EFAVIRENZ (600 Mg/daily, Po; 600 Mg/daily, Po) (View Efavirenz Review and Efavirenz Label ), VIDEX (125 Mg/bid, Po; 300 Mg/daily, Po) (View Videx Review and Videx Label ), INVIRASE (400 Mg/bid, Po; 800 Mg/daily, Po) (View Invirase Review and Invirase Label ), NORVIR (400 Mg/bid, Po; 800 Mg/daily, Po; 100 Mg/daily, Po; 200 Mg Daily, Po,) (View Norvir Review and Norvir Label ).

6557042-X | Abdominal Distension, Cardiac Murmur, Congenital Abdominal Hernia, Congenital Anomaly, Cryptorchism
Patient was taking Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: abdominal distension, cardiac murmur, congenital abdominal hernia, congenital anomaly, cryptorchism on Jan 18, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 6.61 lb, was diagnosed with hiv infection (What is hiv infection?) and. Crixivan dosage: . During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine And Tenofovir Disoproxil Fumarate Review and Emtricitabine And Tenofovir Disoproxil Fumarate Label ), TENOFOVIR DISOPROSIL FUMARATE (VIREAD) (View Tenofovir Disoprosil Fumarate (viread) Review and Tenofovir Disoprosil Fumarate (viread) Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6549168-1 | Lung Neoplasm Malignant
Adverse event was reported on Jan 11, 2010 by a Male patient taking Crixivan (View Usage) (Dosage: Po) was diagnosed with hiv infection (What is hiv infection?) and. Location: DENMARK , 38 years of age, Patient experienced the following unwanted or unexpected effects: lung neoplasm malignant. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6538009-4 | Lung Neoplasm Malignant
on Dec 28, 2009 Male patient from DENMARK , 38 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). Patient had the following side effects: lung neoplasm malignant. Crixivan dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6516647-2 | Immune Reconstitution Syndrome, Progressive Multifocal Leukoencephalopathy
on Dec 18, 2009 Male patient from UNITED KINGDOM , 38 years of age, was diagnosed with progressive multifocal leukoencephalopathy and was treated with Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: immune reconstitution syndrome, progressive multifocal leukoencephalopathy. Crixivan dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ).

6383113-7 | Pathogen Resistance, Virologic Failure
Patient was taking Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: pathogen resistance, virologic failure on Sep 16, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 50 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Crixivan dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6380205-3 | Gastric Varices, Portal Hypertension, Varices Oesophageal
Adverse event was reported on Aug 31, 2009 by a Female patient taking Crixivan (View Usage) (Dosage: Po) . Location: SPAIN , 36 years of age, Patient had the following side effects: gastric varices, portal hypertension, varices oesophageal. During the same period patient was treated with SUSTIVA (View Sustiva Review and Sustiva Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6377505-X | Portal Hypertension
on Sep 15, 2009 Female patient from SPAIN , 46 years of age, was treated with Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: portal hypertension. Crixivan dosage: Po. During the same period patient was treated with SUSTIVA (Po) (View Sustiva Review and Sustiva Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6376705-2 | Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Haemoglobin Decreased, Oesophageal Varices Haemorrhage, Portal Hypertensive Gastropathy, Splenomegaly
on Aug 31, 2009 Male patient from SPAIN , 57 years of age, was treated with Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, haemoglobin decreased, oesophageal varices haemorrhage, portal hypertensive gastropathy, splenomegaly. Crixivan dosage: Po. During the same period patient was treated with SUSTIVA (Po) (View Sustiva Review and Sustiva Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6358976-1 | Ascites, Portal Hypertension, Portal Hypertensive Gastropathy, Splenomegaly, Varices Oesophageal
Patient was taking Crixivan (View Usage). Patient had the following side effects: ascites, portal hypertension, portal hypertensive gastropathy, splenomegaly, varices oesophageal on Aug 31, 2009 from SPAIN Additional patient health information: Female patient , 46 years of age, . Crixivan dosage: Po. During the same period patient was treated with SUSTIVA (Po) (View Sustiva Review and Sustiva Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6358974-8 | Blood Alkaline Phosphatase Increased, Haemoglobin Decreased, Oesophageal Varices Haemorrhage, Portal Hypertension, Portal Hypertensive Gastropathy
Adverse event was reported on Aug 31, 2009 by a Male patient taking Crixivan (View Usage) (Dosage: Po) . Location: SPAIN , 57 years of age, After Crixivan was administered, patient had the following side effects: blood alkaline phosphatase increased, haemoglobin decreased, oesophageal varices haemorrhage, portal hypertension, portal hypertensive gastropathy. During the same period patient was treated with SUSTIVA (Po) (View Sustiva Review and Sustiva Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6279729-9 | Back Pain, Blood Alkaline Phosphatase Increased, Blood Sodium Decreased, Calculus Urinary, Creatinine Renal Clearance Decreased, Cytomegalovirus Chorioretinitis, Decreased Appetite, Dehydration, Dizziness
on Jul 13, 2009 Female patient from JAPAN , 34 years of age, was diagnosed with hiv infection (What is hiv infection?), mycobacterium avium complex infection and was treated with Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), blood alkaline phosphatase increased, blood sodium decreased, calculus urinary, creatinine renal clearance decreased, cytomegalovirus chorioretinitis, decreased appetite, dehydration, dizziness (What is dizziness?). Crixivan dosage: 2.4 Gm/daily Po, 1.2 Gm Daily Po. During the same period patient was treated with CAP STOCRIN (600 Mg Daily Po) (View Cap Stocrin Review and Cap Stocrin Label ), RITONAVIR (400 Mg Daily Po) (View Ritonavir Review and Ritonavir Label ), ABACAVIR SULFATE (300 Mg Bid Po) (View Abacavir Sulfate Review and Abacavir Sulfate Label ), LOPINAVIR AND RITONAVIR (6 Capsule Daily Po) (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), CLARITHROMYCIN (200 Mg Tid Po, 800 Mg Daily Po) (View Clarithromycin Review and Clarithromycin Label ). Patient was hospitalized.

6221238-7 | Small For Dates Baby
on Jun 02, 2008 Female patient from UNITED STATES , weighting 2.20 lb, was treated with Crixivan (View Usage). Patient had the following side effects: small for dates baby. Crixivan dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6198257-2 | Dysgeusia, Dyspepsia, Nephrolithiasis, Product Quality Issue
Patient was taking Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: dysgeusia, dyspepsia, nephrolithiasis, product quality issue on Mar 25, 2008 from UNITED STATES Additional patient health information: Male patient , 64 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Crixivan dosage: 800 Mg/tid/po. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ). Patient was hospitalized.

6198255-9 | Blood Cholesterol Increased, Blood Triglycerides Increased, Myocardial Infarction
Adverse event was reported on Jul 23, 2008 by a Male patient taking Crixivan (View Usage) (Dosage: 400 Mg/bid/po) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 56 years of age, Patient experienced the following unwanted or unexpected effects: blood cholesterol increased, blood triglycerides increased, myocardial infarction. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

6143843-9 | Anaemia, Bacterial Infection, Bronchopulmonary Aspergillosis, Chest Pain, Cytomegalovirus Infection, Leukopenia, Oesophageal Candidiasis
on Mar 24, 2009 Female patient from BRAZIL , 33 years of age, was diagnosed with antifungal prophylaxis and was treated with Crixivan (View Usage). Patient had the following side effects: anaemia, bacterial infection (What is bacterial infection?), bronchopulmonary aspergillosis, chest pain (What is chest pain?), cytomegalovirus infection (What is cytomegalovirus infection?), leukopenia, oesophageal candidiasis. Crixivan dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ).

6105857-4 | Arthralgia, Nephritis, Pyelonephritis Chronic, Pyuria, Renal Atrophy, Renal Failure, Urinary Sediment Abnormal
on Feb 24, 2009 Male patient from JAPAN , 31 years of age, weighting 147.7 lb, was diagnosed with hiv infection (What is hiv infection?), arthralgia, infection prophylaxis, haemarthrosis and was treated with Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: arthralgia, nephritis, pyelonephritis chronic, pyuria, renal atrophy, renal failure, urinary sediment abnormal. Crixivan dosage: . During the same period patient was treated with HIVID (View Hivid Review and Hivid Label ), LOXONIN (View Loxonin Review and Loxonin Label ), BANAMBAX (View Banambax Review and Banambax Label ), KOGENATE (View Kogenate Review and Kogenate Label ).

6084121-6 | Dehydration, Pneumonia, Renal Failure Acute
Patient was taking Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, pneumonia (What is pneumonia?), renal failure acute on Feb 17, 2009 from UNITED STATES Additional patient health information: Male patient , 48 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Crixivan dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), SUSTIVA (View Sustiva Review and Sustiva Label ). Patient was hospitalized.

6072299-X | Dizziness, Dry Mouth, Headache, Hypotension, Malaise, Nausea
Adverse event was reported on Feb 04, 2009 by a Female patient taking Crixivan (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), suppressed lactation and. Location: FRANCE , 36 years of age, Patient had the following side effects: dizziness (What is dizziness?), dry mouth, headache (What is headache?), hypotension, malaise, nausea (What is nausea?). During the same period patient was treated with LAMIVUDINE AND ZIDOVUDINE (View Lamivudine And Zidovudine Review and Lamivudine And Zidovudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), BROMOCRIPTINE (View Bromocriptine Review and Bromocriptine Label ), CAFFEINE AND DIHYDROERGOCRYPTINE MESYLATE (View Caffeine And Dihydroergocryptine Mesylate Review and Caffeine And Dihydroergocryptine Mesylate Label ). Patient was hospitalized.

6035965-8 | Dehydration, Pneumonia, Renal Failure
on Jan 07, 2009 Male patient from UNITED STATES , 45 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: dehydration, pneumonia (What is pneumonia?), renal failure. Crixivan dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ). Patient was hospitalized.

6027992-1 | Blood Bilirubin Increased, Blood Pressure Decreased, Diabetes Mellitus, Diabetic Neuropathy, Haemodialysis, Hyperuricaemia, Jaundice, Pancytopenia, Renal Failure
on Dec 17, 2008 Male patient from JAPAN , 47 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, blood pressure decreased, diabetes mellitus, diabetic neuropathy, haemodialysis, hyperuricaemia, jaundice (What is jaundice?), pancytopenia, renal failure. Crixivan dosage: 800 Mg/tid. During the same period patient was treated with EPIVIR (150 Mg/bid; 50 Mg/daily) (View Epivir Review and Epivir Label ), ZERIT (30 Mg/bid) (View Zerit Review and Zerit Label ), VIRACEPT (1000 Mg/bid) (View Viracept Review and Viracept Label ), COTRIM (View Cotrim Review and Cotrim Label ), BANAMBAX (View Banambax Review and Banambax Label ), HIVID (View Hivid Review and Hivid Label ), LOPEMIN (View Lopemin Review and Lopemin Label ). Patient was hospitalized and became disabled.

5923974-6 | Anaemia, Blood Pressure Decreased, Diabetes Mellitus, Diabetes Mellitus Inadequate Control, Diabetic Nephropathy, Disease Complication, Haemodialysis, Hypertension, Hyperuricaemia
Patient was taking Crixivan (View Usage). Patient had the following side effects: anaemia, blood pressure decreased, diabetes mellitus, diabetes mellitus inadequate control, diabetic nephropathy, disease complication, haemodialysis, hypertension, hyperuricaemia on Oct 01, 2008 from JAPAN Additional patient health information: Male patient , 47 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Crixivan dosage: 800 Mg/tid Po. During the same period patient was treated with EPIVIR (150 Mg/bid Po, 50 Mg/daily Po) (View Epivir Review and Epivir Label ), ZERIT (30 Mg/bid Po) (View Zerit Review and Zerit Label ), VIRACEPT (1000 Mg/bid Po) (View Viracept Review and Viracept Label ), COTRIM (View Cotrim Review and Cotrim Label ), BANAMBAX (View Banambax Review and Banambax Label ), HIVID (View Hivid Review and Hivid Label ), LOPEMIN (View Lopemin Review and Lopemin Label ). Patient was hospitalized and became disabled.

5918523-2 | Blood Pressure Decreased, Diabetes Mellitus, Diabetic Nephropathy, Haemodialysis, Hypertension, Hyperuricaemia, Jaundice, Pancytopenia, Renal Failure
Adverse event was reported on Oct 01, 2008 by a Male patient taking Crixivan (View Usage) (Dosage: 800 Mg/tid Po) was diagnosed with hiv infection (What is hiv infection?) and. Location: JAPAN , 47 years of age, After Crixivan was administered, patient had the following side effects: blood pressure decreased, diabetes mellitus, diabetic nephropathy, haemodialysis, hypertension, hyperuricaemia, jaundice (What is jaundice?), pancytopenia, renal failure. During the same period patient was treated with EPIVIR (150 Mg/bid Po, 50 Mg/daily Po) (View Epivir Review and Epivir Label ), ZERIT (30 Mg/bid Po) (View Zerit Review and Zerit Label ), VIRACEPT (1000 Mg/bid Po) (View Viracept Review and Viracept Label ), BAKTAR (View Baktar Review and Baktar Label ), BANAMBAX (View Banambax Review and Banambax Label ), HIVID (View Hivid Review and Hivid Label ), LOPEMIN (View Lopemin Review and Lopemin Label ). Patient was hospitalized and became disabled.

5900761-6 | Osteonecrosis
on Sep 09, 2008 Male patient from SPAIN , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Crixivan dosage: .

5886495-5 | Osteonecrosis
on Sep 09, 2008 Male patient from SPAIN , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Crixivan dosage: .

5885126-8 | Malignant Melanoma, Metastases To Lymph Nodes, Metastases To Skin
Patient was taking Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: malignant melanoma, metastases to lymph nodes, metastases to skin on Sep 12, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 69 years of age, . Crixivan dosage: . During the same period patient was treated with NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

5883347-1 | Body Fat Disorder, Lipoma
Adverse event was reported on Sep 12, 2008 by a Male patient taking Crixivan (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 155.0 lb, Patient experienced the following unwanted or unexpected effects: body fat disorder, lipoma. During the same period patient was treated with ZERIT (View Zerit Review and Zerit Label ), EPIVIR (View Epivir Review and Epivir Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), TRUVADA (View Truvada Review and Truvada Label ), ATRIPLA (View Atripla Review and Atripla Label ).

5818481-5 | Anaemia, Dyslipidaemia, Hypercholesterolaemia, Hypertriglyceridaemia, Neuropathy Peripheral, Osteonecrosis, Osteopenia, Pancreatitis Acute
on May 19, 2008 Female patient from , 18 years of age, was treated with Crixivan (View Usage). Patient had the following side effects: anaemia, dyslipidaemia, hypercholesterolaemia, hypertriglyceridaemia, neuropathy peripheral, osteonecrosis (What is osteonecrosis?), osteopenia, pancreatitis acute. Crixivan dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ABACAVIR SULFATE (View Abacavir Sulfate Review and Abacavir Sulfate Label ), EPIVIR (View Epivir Review and Epivir Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ).

5812687-7 | Abortion Induced, Alcohol Use, Tobacco User
on Aug 15, 2007 Female patient from UNITED STATES , 29 years of age, was treated with Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: abortion induced, alcohol use, tobacco user. Crixivan dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

5812667-1 | Premature Labour
Patient was taking Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: premature labour on Aug 15, 2007 from UNITED STATES Additional patient health information: Female patient , 27 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Crixivan dosage: .

5812664-6 | Fallot's Tetralogy, Pregnancy
Adverse event was reported on Aug 15, 2007 by a Female patient taking Crixivan (View Usage) (Dosage: ) . Location: UNITED STATES , 29 years of age, Patient had the following side effects: fallot's tetralogy, pregnancy (What is pregnancy?). During the same period patient was treated with SUSTIVA (View Sustiva Review and Sustiva Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

5812659-2 | Abortion Induced, Alcohol Use, Pregnancy
on Aug 15, 2007 Female patient from UNITED STATES , 30 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: abortion induced, alcohol use, pregnancy (What is pregnancy?). Crixivan dosage: . During the same period patient was treated with ZERIT (View Zerit Review and Zerit Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

5812658-0 | Congenital Cardiovascular Anomaly, Congenital Tricuspid Valve Atresia, Congenital Tricuspid Valve Stenosis, Hypoplastic Right Heart Syndrome, Premature Baby, Small For Dates Baby, Ventricular Septal Defect
on Aug 15, 2007 Female patient from UNITED STATES , 31 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: congenital cardiovascular anomaly, congenital tricuspid valve atresia, congenital tricuspid valve stenosis, hypoplastic right heart syndrome, premature baby, small for dates baby, ventricular septal defect. Crixivan dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

5811580-3 | Renal Papillary Necrosis
Patient was taking Crixivan (View Usage). Patient had the following side effects: renal papillary necrosis on Jul 02, 2008 from BELGIUM Additional patient health information: Male patient , 39 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Crixivan dosage: . During the same period patient was treated with ZALCITABINE (View Zalcitabine Review and Zalcitabine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

5808914-2 | Renal Papillary Necrosis
Adverse event was reported on Jul 02, 2008 by a Male patient taking Crixivan (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: BELGIUM , 39 years of age, After Crixivan was administered, patient had the following side effects: renal papillary necrosis. During the same period patient was treated with ZALCITABINE (View Zalcitabine Review and Zalcitabine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

5806120-9 | Renal Papillary Necrosis
on Jul 02, 2008 Male patient from BELGIUM , 39 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: renal papillary necrosis. Crixivan dosage: . During the same period patient was treated with ZALCITABINE (View Zalcitabine Review and Zalcitabine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

5794682-X | Osteonecrosis
on Jun 18, 2008 Male patient from MOROCCO , 36 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Crixivan dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ).

5794149-9 | Bundle Branch Block Right, Coronary Artery Occlusion, Haematuria, High Density Lipoprotein Decreased, Hyperbilirubinaemia, Hypercholesterolaemia, Hypertension, Hypertriglyceridaemia
Patient was taking Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: bundle branch block right, coronary artery occlusion, haematuria, high density lipoprotein decreased, hyperbilirubinaemia, hypercholesterolaemia, hypertension, hypertriglyceridaemia on May 19, 2008 from Additional patient health information: Female patient , 19 years of age, . Crixivan dosage: . During the same period patient was treated with STOCRIN (View Stocrin Review and Stocrin Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ZALCITABINE (View Zalcitabine Review and Zalcitabine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ABACAVIR SULFATE (View Abacavir Sulfate Review and Abacavir Sulfate Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), KALETRA (View Kaletra Review and Kaletra Label ).

5772128-5 | Anaemia, Dyslipidaemia, Hypercholesterolaemia, Hypertriglyceridaemia, Neuropathy Peripheral, Osteonecrosis, Osteopenia, Pancreatitis Acute
Adverse event was reported on May 19, 2008 by a Female patient taking Crixivan (View Usage) (Dosage: ) . Location: , 18 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, dyslipidaemia, hypercholesterolaemia, hypertriglyceridaemia, neuropathy peripheral, osteonecrosis (What is osteonecrosis?), osteopenia, pancreatitis acute. During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ABACAVIR SULFATE (View Abacavir Sulfate Review and Abacavir Sulfate Label ), EPIVIR (View Epivir Review and Epivir Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), ABACAVIR SULFATE AND LAMIVUDINE AND ZIDOVUDINE (View Abacavir Sulfate And Lamivudine And Zidovudine Review and Abacavir Sulfate And Lamivudine And Zidovudine Label ).

5767412-5 | Bundle Branch Block Right, Coronary Artery Occlusion, Haematuria, High Density Lipoprotein Decreased, Hyperbilirubinaemia, Hypercholesterolaemia, Hypertension, Hypertriglyceridaemia
on May 19, 2008 Female patient from , 19 years of age, was treated with Crixivan (View Usage). Patient had the following side effects: bundle branch block right, coronary artery occlusion, haematuria, high density lipoprotein decreased, hyperbilirubinaemia, hypercholesterolaemia, hypertension, hypertriglyceridaemia. Crixivan dosage: . During the same period patient was treated with STOCRIN (View Stocrin Review and Stocrin Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ZALCITABINE (View Zalcitabine Review and Zalcitabine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ABACAVIR SULFATE (View Abacavir Sulfate Review and Abacavir Sulfate Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), KALETRA (View Kaletra Review and Kaletra Label ).

5745365-3 | No Therapeutic Response, Pathological Fracture
on May 07, 2008 Female patient from SPAIN , child 12 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: no therapeutic response, pathological fracture. Crixivan dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

5742335-6 | Abdominal Pain Lower, Abdominal Pain Upper, Bone Neoplasm, Cellulitis Staphylococcal, Clavicle Fracture, Cough, Diabetes Mellitus, Malaise, Nausea
Patient was taking Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain lower, abdominal pain upper, bone neoplasm, cellulitis staphylococcal, clavicle fracture, cough, diabetes mellitus, malaise, nausea (What is nausea?) on Apr 19, 2007 from UNITED STATES Additional patient health information: Male patient , 24 years of age, weighting 250.0 lb, was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?), cellulitis staphylococcal and. Crixivan dosage: 800 Mg/tid/po. During the same period patient was treated with CLINDAMYCIN HYDROCHLORIDE (900 Mg/q8h/iv) (View Clindamycin Hydrochloride Review and Clindamycin Hydrochloride Label ), EPIVIR (View Epivir Review and Epivir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

5737817-7 | No Therapeutic Response, Pathological Fracture
Adverse event was reported on May 07, 2008 by a Female patient taking Crixivan (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: SPAIN , child 12 years of age, Patient had the following side effects: no therapeutic response, pathological fracture. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

5712928-0 | Metabolic Acidosis, Nephritis Interstitial, Renal Impairment
on Apr 14, 2008 Male patient from ITALY , 31 years of age, was diagnosed with acute hiv infection (What is acute hiv infection?) and was treated with Crixivan (View Usage). After Crixivan was administered, patient had the following side effects: metabolic acidosis, nephritis interstitial, renal impairment. Crixivan dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

5708283-2 | Angiolipoma, Lipodystrophy Acquired
on Apr 09, 2008 Female patient from SPAIN , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Crixivan (View Usage). Patient experienced the following unwanted or unexpected effects: angiolipoma, lipodystrophy acquired. Crixivan dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ).

5707201-0 | Angiolipoma, Lipodystrophy Acquired
Patient was taking Crixivan (View Usage). Patient had the following side effects: angiolipoma, lipodystrophy acquired on Apr 09, 2008 from SPAIN Additional patient health information: Female patient , 41 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Crixivan dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).